Johannesburg, 19th September 2011 - An agreement undertaken by Litha Pharma (Pty) Ltd, a subsidiary of the group, will see the healthcare group further increasing its generics product portfolio.

Litha Healthcare Group Limited, today announced the signing of an exclusive agreement with Natco Pharma, a leading Indian based generic pharmaceutical manufacturer. Under the Group’s newly formed generics business unit, the agreement will include a range of generic pharmaceutical products developed and manufactured by Natco.   Litha Pharma (Pty) Ltd will manage the submission and distribution of the products into the South African market and adjacent territories. The range of products includes molecules which have presented challenges to other companies in both the development and intellectual property areas.

More…..